{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:08:36Z","timestamp":1791119316233,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T00:00:00Z","timestamp":1365379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T00:00:00Z","timestamp":1365379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/bmt.2013.49","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T10:40:12Z","timestamp":1365417612000},"page":"1313-1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML"],"prefix":"10.1038","volume":"48","author":[{"given":"S","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Pophali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"CO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E K","family":"Koklanaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Superata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"Fahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"BFbmt201349_CR1","first-page":"7","volume":"8","author":"DJ Winston","year":"1991","unstructured":"Winston DJ, Gale RP . Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplant 1991; 8: 7\u201311.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201349_CR2","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","volume":"88","author":"M Boeckh","year":"1996","unstructured":"Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA . Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063\u20134071.","journal-title":"Blood"},{"key":"BFbmt201349_CR3","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood.V86.7.2815.2815","volume":"86","author":"H Einsele","year":"1995","unstructured":"Einsele H, Ehninger G, Hebart H, Wittkowski KM, Schuler U, Jahn G et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995; 86: 2815\u20132820.","journal-title":"Blood"},{"key":"BFbmt201349_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","volume":"13","author":"M Battiwalla","year":"2007","unstructured":"Battiwalla M, Wu Y, Bajwa RP, Radovic M, Almyroudis NG, Segal BH et al. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant 2007; 13: 765\u2013770.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201349_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","volume":"103","author":"M Boeckh","year":"2004","unstructured":"Boeckh M, Nichols WG . The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004; 103: 2003\u20132008.","journal-title":"Blood"},{"key":"BFbmt201349_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","volume":"9","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J . Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003; 9: 543\u2013558.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201349_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/338624","volume":"185","author":"WG Nichols","year":"2002","unstructured":"Nichols WG, Corey L, Gooley T, Davis C, Boeckh M . High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185: 273\u2013282.","journal-title":"J Infect Dis"},{"key":"BFbmt201349_CR8","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011; 118: 1402\u20131412.","journal-title":"Blood"},{"key":"BFbmt201349_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbmt.2008.10.023","volume":"15","author":"CE Behrendt","year":"2009","unstructured":"Behrendt CE, Rosenthal J, Bolotin E, Nakamura R, Zaia J, Forman SJ . Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy. Biol Blood Marrow Transplant 2009; 15: 54\u201360.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201349_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.bmt.1703928","volume":"31","author":"SR Solomon","year":"2003","unstructured":"Solomon SR, Nakamura R, Read EJ, Leitman SF, Carter C, Childs R et al. Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant 2003; 31: 783\u2013788.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201349_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1086\/339329","volume":"34","author":"P Ljungman","year":"2002","unstructured":"Ljungman P, Griffiths P, Paya C . Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094\u20131097.","journal-title":"Clin Infect Dis"},{"key":"BFbmt201349_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/378413","volume":"188","author":"KJ Cortez","year":"2003","unstructured":"Cortez KJ, Fischer SH, Fahle GA, Calhoun LB, Childs RW, Barrett AJ et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis 2003; 188: 967\u2013972.","journal-title":"J Infect Dis"},{"key":"BFbmt201349_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/bmt.2011.194","volume":"47","author":"HJ Khoury","year":"2011","unstructured":"Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M et al. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis. Bone Marrow Transplant 2011; 47: 810\u2013816.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201349_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/sim.4780091214","volume":"9","author":"RB D'Agostino","year":"1990","unstructured":"D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB . Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990; 9: 1501\u20131515.","journal-title":"Stat Med"},{"key":"BFbmt201349_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bmt.1705167","volume":"36","author":"BN Savani","year":"2005","unstructured":"Savani BN, Montero A, Kurlander R, Childs R, Hensel N, Barrett AJ . Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36: 1009\u20131015.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201349_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbmt.2003.08.011","volume":"10","author":"R Nakamura","year":"2004","unstructured":"Nakamura R, Battiwalla M, Solomon S, Follmann D, Chakrabarti S, Cortez K et al. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 2004; 10: 49\u201357.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201349_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbmt.2006.05.008","volume":"12","author":"R Parkman","year":"2006","unstructured":"Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 919\u2013927.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201349_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/leu.2011.195","volume":"26","author":"M Hoegh-Petersen","year":"2012","unstructured":"Hoegh-Petersen M, Sy S, Ugarte-Torres A, Williamson TS, Eliasziw M, Mansoor A et al. High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantation. Leukemia 2012; 26: 359\u2013362.","journal-title":"Leukemia"},{"key":"BFbmt201349_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1182\/blood-2011-10-383943","volume":"119","author":"KJ Thomson","year":"2012","unstructured":"Thomson KJ, Mackinnon S, Peggs KS . CMV-specific cellular therapy for acute myeloid leukemia? Blood 2012; 119: 1088\u20131090.","journal-title":"Blood"},{"key":"BFbmt201349_CR20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood-2011-06-354340","volume":"118","author":"AJ Barrett","year":"2011","unstructured":"Barrett AJ . CMV: when bad viruses turn good. Blood 2011; 118: 1193\u20131194.","journal-title":"Blood"},{"key":"BFbmt201349_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/sj.leu.2402748","volume":"17","author":"S Hermouet","year":"2003","unstructured":"Hermouet S, Sutton CA, Rose TM, Greenblatt RJ, Corre I, Garand R et al. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia 2003; 17: 185\u2013195.","journal-title":"Leukemia"},{"key":"BFbmt201349_CR22","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.161.5.2365","volume":"161","author":"JM Fletcher","year":"1998","unstructured":"Fletcher JM, Prentice HG, Grundy JE . Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J Immunol 1998; 161: 2365\u20132374.","journal-title":"J Immunol"},{"key":"BFbmt201349_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","volume":"119","author":"M Della Chiesa","year":"2012","unstructured":"Della Chiesa M, Falco M, Podesta M, Locatelli F, Moretta L, Frassoni F et al. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 2012; 119: 399\u2013410.","journal-title":"Blood"},{"key":"BFbmt201349_CR24","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","volume":"119","author":"B Foley","year":"2011","unstructured":"Foley B, Cooley S, Verneris MR, Pitt M, Curtsinger J, Luo X et al. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2011; 119: 2665\u20132674.","journal-title":"Blood"},{"key":"BFbmt201349_CR25","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1182\/blood-2005-05-1897","volume":"107","author":"BN Savani","year":"2006","unstructured":"Savani BN, Rezvani K, Mielke S, Montero A, Kurlander R, Carter CS et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood 2006; 107: 1688\u20131695.","journal-title":"Blood"},{"key":"BFbmt201349_CR26","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1182\/blood-2011-06-361618","volume":"118","author":"F Milano","year":"2011","unstructured":"Milano F, Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I et al. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients. Blood 2011; 118: 5689\u20135696.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201349","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T21:44:29Z","timestamp":1688161469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFbmt201349"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2013.49","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,8]]},"assertion":[{"value":"9 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}